RBM SpA – Merck Serono SpA

The Institute of Biomedical Research RBM has a long history of preclinical developing and supporting  to clinical development. The Institute is a 100% subsidiary of Merck Serono and it is today one of the most important research sites for the company.

In 1999, LCS realized for RBM the cell bank depository management at the headquarters in Colleretto Giacosa (TO) and today it takes care of the maintenance activities.